Otello Stampacchia bought $30M of WWB
Director at WINDWARD BIO GROUP AG. 1,750,000 shares at an average of $17.00, traded Nov 16, 2026, filed Nov 18, 2026.
Score components
This filing reached EDGAR on Nov 18, 2026, so its score and components open to free visitors on Nov 25, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001361712-26-000011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | POpen-market purchase Common Sharesindirect: By Omega Fund VII, L.P. | +875,000 | $17.00 | $15M | 875,000 | 15 h ago |
| Nov 16, 2026 | POpen-market purchase Common Sharesindirect: By Omega Fund VIII, L.P. | +875,000 | $17.00 | $15M | 875,000 | 15 h ago |
| Nov 16, 2026 | CConversion Common Sharesindirect: By Omega Fund VII, L.P. | +1,262,628 | - | - | 2,137,628 | 15 h ago |
| Nov 16, 2026 | CConversion Common Sharesindirect: By Omega Fund VIII, L.P. | +1,262,626 | - | - | 2,137,626 | 15 h ago |
| Nov 16, 2026 | CConversion Common Sharesindirect: By Omega Fund VII, L.P. | +531,632 | - | - | 2,669,260 | 15 h ago |
| Nov 16, 2026 | CConversion Common Sharesindirect: By Omega Fund VIII, L.P. | +531,634 | - | - | 2,669,260 | 15 h ago |
| Nov 16, 2026 | CConversion Series A Preferred Sharesderivativeindirect: By Omega Fund VII, L.P. | -1,262,628 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | CConversion Series A Preferred Sharesderivativeindirect: By Omega Fund VIII, L.P. | -1,262,626 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | CConversion Series B Preferred Sharesderivativeindirect: By Omega Fund VII, L.P. | -531,632 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | CConversion Series B Preferred Sharesderivativeindirect: By Omega Fund VIII, L.P. | -531,634 | $0.00 | $0 | 0 | 15 h ago |
Related signals
Other insiders at WINDWARD BIO GROUP AG and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Nov 25, 2026 | WINDWARD BIO GROUP AG | David P Bonita Director and 10% owner | $20M 1,176,471 shares | +221% | |
| Pro nowfree Nov 25, 2026 | WINDWARD BIO GROUP AG | Orbimed Advisors LLC Director and 10% owner | $20M 1,176,471 shares | +221% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.